chrisvoncsefalvay/vaers-outcomes huggingface dataset:
runny nose, sore throat, cough, nasal congestion started 10/6/22 tested positive in rapid home Covid test on 10/8/22 prescribed Paxlovid on 10/8/22 symptoms gradually improving as of 10/12/22
30 hours after the vaccination she developed redness and weeping in her left eye. She was taken to urgent care and diagnosed with pink eye and rescribed Polymoxin.
Injection given at 10:39 AM. HR increased in 30 minutes, later to 120. At 11:40, she noted pruritis on arms and rash erupted - fine; erythema, warmth,  HR 8, R 18, Pulse ox 97%, lungs clear.  At 11:45, she noted tingling of the tongue, but no enlargement. Benadryl 25mg given PO at this time. At 12:00, she noted fingers tingling. At 12:20: HR 98, pulseox 97%.  At 12:25: Rash, pruritis on right leg just below knees and behind the left knee.
Patient recieved a flu vaccination on 1/14/23 after they had already recieved one this season on 11/17/22. No adverse event or outcomes noted.
Face and neck numb for more than an hour. Heart palpitations for 1 hour. Watery eyes and dilated for 4 hours because I took ZYRTEC 10mg ( medicine I take during allergies).
Falling, difficulty standing and walking, knees and hips give out periodically. Symptoms still going on as of this report 06/29/2017. Diagnosed with Conversion Disorder 05/27/2017, physical therapy ordered.
Chronic urticaria/Grover's disease which began 2 weeks post influenza vaccine.
Fever- 22:00- TX- NSAID Muscle aches- 19:00
When the needle entered my arm, that felt normal. But I felt extreme pressure and immediate pain as soon as the plunger got depressed. After the needle was removed, I continued to feel pain within my shoulder, not at the injection site.  On my ride home, the pain started to worsen and was very painful when I got home, throughout my shoulder joint.  I took Advil when I got home, and have taken it very 6 hours since, along with lots of water.  I have used a heating pad with some immediate relief but no improvement in the pain.  I am trying to stretch and move the arm, but am requiring assistance with even that because of how much pain is involved with simple movements.  It does not seem nerve related as it does not radiate down my arm.  The pain is isolated to my shoulder joint.
Red itchy rash, splotchy, fever, loss of appetite; onset 11 days after vaccine administered. Iburprofen, Benadryl.
Within 10 minutes of getting the vaccination my face started feeling tight and I started feeling discomfort in my throat.  By the time the 15 minutes was up my face and lips were completely swollen and I started feeling lightheaded.  I  was given steroids and Benadryl through an IV and was given an EpiPen injection.
101.5 degree fever, chills, body aches, headache, severe fatigue for 36+ hours
(R) arm pain radiating down arm & up side of (R) neck. Swelling at the site 9 days out. Decreased ROM. Pt. referral; ADVIL.
patient accidentally received a third dose / patient receiving a 3 dose by accident; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number AEQJ4, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 5th January 2020) and Shingrix (2nd dose received on 24th June 2020).   On 23rd August 2021, the patient received the 3rd dose of Shingrix. On 23rd August 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The reporter stated that, the patient accidentally received a third dose of Shingrix, which led to extra dose administered. The reporter consented to follow up.
Missing second shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missing second shot) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missing second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missing second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Swollen lymph gland, tiredness, sore throat, t99.4; seen by MD 29JUL;
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. In July 2019, between 2 and 3 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The reporter stated that, the patient received 1st dose of Shingrix 3 months before the reporting date but developed shingles 1 month before the reporting date. The reporter was unsure if patient actually received the shingles vaccination or not because it is not documented in their system and also he did not provide patients initials and date of birth. The reporter did not consent to follow-up.
Vertigo, migraine, nausea , loss of appetite/loss of thirst, altered mental status Started about 3 days after I got the shot.  Currently taking meclizine for dizziness and butalibital for migraine
Bilateral Swollen cervical(neck) lymph nodes, staying persistently enlarged; This is a spontaneous report from a contactable nurse. A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1284) via an unspecified route of administration in the left arm on 22Dec2020 (at the age of 30-years-old) as a single dose for COVID-19 immunisation.  Medical history included allergic to sulfa antibiotics. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 28Dec2020 at 12:00, the patient experienced bilateral swollen cervical(neck) lymph nodes and it was staying persistently enlarged. The patient did not receive any treatment for the reported events. The adverse event resulted in a visit to the doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 31Mar2021, the patient underwent SARS-CoV-2 (nasal swab) test and the result was negative. The clinical outcome of the event bilateral swollen cervical(neck) lymph nodes was not recovered at the time of this report. The patient received the second dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3248) ia an unspecified route of administration in the left arm on 12Jan2021(at the age of 30-year-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
I experienced a TIA and/or a CVA on 1/6/2022 at approximately 2:30 p.m. and was taken by ambulance to Hospital where I was admitted overnight for observation and tests. On 1/10/2022 at approximately 4:00 a.m. I got up to void and fell into the shower area ; I was taken by ambulance to Hospital where I was diagnosed with a stroke and was airlifted to different Hospital where I was admitted  till Wednesday, January 12, 2022.
This spontaneous report was received from a registered nurse who refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 31-JUL-2018, the patient was vaccinated with VARIVAX lot # R003301, expiration date 01-FEB-2020 (dose and route of administration were not reported) which was reconstituted with sterile diluent (STERILE DILUENT) (lot # and expiration date were not reported) for prophylaxis. The VARIVAX was administered 40 minutes after reconstitution. No adverse effects were reported.
Local reaction at injection site with erythema, hard 5-6cm induration with hot to touch.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Patient has anthrax vaccines #2 and denies any significant local or systemic symptoms. After anthrax vaccine #3 in 2000, denies significant systemic symptoms. She did develop a pruritic, subcutaneous nodule that lasted approximately 2 months and then resolved. In August 2003, patient noted what looked like a pimple on her upper left arm where she had received anthrax vaccine #3. It then became about the size of pea that was pruritic and had remained for over 1 year. In January 2004, she noted a similar nodule on her right arm at the site of her previous anthrax vaccine (#2); she continues to have a pruritic, pea-size nodule. The itching decreases/subsides with the application of topical steroids, but returns if use is discontinued.
12 days after receiving the vaccine the patient developed red painful bruises to both feet that start mildly, but continued to worsen over the next several days.  The patient went to see his dermatologist and was diagnosed with Leukocytodastic Vasculitis.
Mother states that her son has a dent in his leg. She took him to see the doctor on 01/02/01. She said it was caused by a vaccine. She couldn't tell me which vaccine would have caused it. She said it was showing up now because he is growing. She said it has damaged a muscle. This was not listed on any consent form as a possible side effect.
After 3rd dose, got severe rigors that lasted 2 -2.5 hours
Hepatitis B, Hepatitis B e antigen positive, Hepatitis B antibody positive, Therapy non-responder; This case was reported by a physician and described a 49-year0old female patient who tested positive for hepatitis B following immunization with hepatitis B vaccine recombinant (Engerix-B). The patient's medical history was notable for hepatitis B exposure from "two brothers who have hepatitis B." On an unspecified date in December 2000, the patient "tested negative for hepatitis B." The patient received a series of three doses of Engerix-B on 09 January 2001, 08 February 2001 and 12 July 2001. The lot number for all three doses of Engerix-B is ENG5160D9. The reporter stated that, "A titer was not done when the series was completed." On an unspecified date in September 2004, the patient was donating blood and "tested positive for hepatitis B." She was seen at a physician's office. Laboratory analyses revealed that the antibody to hepatitis B core antigen was "non-reactive," hepatitis B surface antigen was "non-reactive," IgM antibody to hepatitis B surface antigen was "non-reactive," hepatitis Be antigen was positive, antibody to hepatitis Be antigen was positive and polymerase chain reaction by focus technology revealed 8700 copies/ml of hepatitis B virus.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The patient experienced no adverse events.   This case was linked to MOD-2021-395985 (Patient Link).
Amenorrhea.  Patient has experienced a disrupted menstrual cycle not due to pregnancy. Other causes were ruled out.
Child was tested for Pertussis on 5/22/10.  State lab reported PCR positive with Cultures pending.
EYES FLARED UP; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (EYES FLARED UP) and CHILLS (CHILLS) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe ).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In June 2021, the patient experienced EYE DISORDER (EYES FLARED UP). On an unknown date, the patient experienced CHILLS (CHILLS). In October 2021, EYE DISORDER (EYES FLARED UP) had resolved. At the time of the report, CHILLS (CHILLS) had resolved.            No relevant concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medication reported.   The reporter's causality for the event(s) of eyes flared up was not provided. The reporter's causality for the event(s) of chills with HUMIRA(ADALIMUMAB) was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Case number PHEH213US010663, is an initial spontaneous report from a nurse on 13 May 2013. This report refers to an 11 year-old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with MENVEO (batch number: 12023) subcutaneously on 10 May 2013. No adverse event was reported following this administration error.
12 hours post shot ran fever. Saturday went to ER. Pneumonia and dehydrated. Placed on antibiotics. Had pneumonia again 1yr later (2/03). Developed asthma 10/03. Started with tonsillitis. Child appeared to be healthy until this shot.
Patient was given refrigerated Moderna that was expired beyond it's 'Beyond Use Label' date of 01/27/2022.  Vial was placed into fridge on 12/28/2021.  Vial was not removed from fridge in time for 'Beyond Use' expiry date and inadvertently administered.  Manufacturer's expiry date is March 25, 2022.  Provider informed.  Moderna informed and stated that 'the vaccine administered on January 28 to February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (covid 19) virus at time of administration'.   No adverse effects noted or voiced from patient.
Vaccinated 10-09-07.  No symptoms reported at follow-up on 10-16-07.  Rash & itching began 11-18-07.  PCP prescribed acyclovir & hydroxyzine on 11-20-07.  Rash has crusted over.  Still itching at time of report.
Child developed a generalized erythematous maculopapular rash 9 days after immunizations were given. Child had no fevers, no cough, no emesis or diarrhea. He has been eating well, playful. No sick contacts at home. Observation recommended, supportive care. Explained to parents, it was probable adverse event due MMR vaccine.
Swelling and sore arm - treated in walk-in care on 8/22/13. Treated w/ Medrol and Cephalexin - diagnosed w/ cellulitis.
After an hour or so of my shot the left side of my face felt numb and was itchy.  To explain the numbness it was like what your face feels like after getting your mouth numb to have dental work done.   It lasted all day.  The numbness has went away but still doesn't feel right.  3 days after my shot i got a severe sunburn on the arm I received my shot.  I don't normally sunburn and I was under a tent most of the day.
The patient was given a monovalent Moderna vaccine instead of the bivalent vaccine. The company that gave the patient the first two vaccines had a documentation error and reported Moderna was given as first vaccine 7/19/2022 and second dose was pfizer on 9/2/2022. After the fact, this company admitted they gave Moderna instead of pfizer, leading us to a vaccine error of giving a 3rd monovalent vaccine dose.
Patient reports she received the second dose of her COVID vaccine on 3/17.  On 3/23 she developed an itchy, red, warm rash at the injection site which she measured at 7inx3in.  She took a Benadryl and the itching went away.  This morning (3/24) the rash is significantly smaller and lighter in color.  The itching and warmth has resolved, patient does not have a fever.  Patient was advised that we have seen this localized injection site reaction anywhere from 1-10 days after the vaccination and that it normally resolves within 24-36 hours.  Patient was agreeable to call if the redness returns or if she develops a feve
11/05 Adm 6pm, in 2hrs fever, headache, redness at site lack of energy, local urticaria extending down right arm.
I had chills, headache, severe muscle and joint pain. They lasted a total of 48 hours. Pretty bad chills and fever, enough to make me stay in bed. After that I've been fine. I took PAXLOVID. I must have gotten COVID-19 somewhere while traveling.
Pt had severe persistent painful dysesthesias s/p rabies vax; myalgias & paresthesias; some tingling in extremities, devel aching in posterior neck, numbness around lips, soreness, poss neuromuscular toxic reaction; also exhausted, frustrat
Headache; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis. Concomitant products included ADALIMUMAB (HUMIRA) for Psoriatic arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache) and PYREXIA (Fever) had resolved. Not Provided          It was reported that the patient received both doses of vaccination in 2021.  No concomitant medications reported.  Patient experienced headache and fever in 2021.  Treatment of the events were not reported.
He was admitted to Cardiovascular Medicine on 4/11/21 with acute idiopathic myocarditis, the etiology was unclear but considered due to recent COVID vaccination vs viral infection. He presented with elevated troponin and initially elevated ESR and CRP. CTA of coronary arteries was on done on 4/12 and showed normal coronary arteries. TTE was done on 4/13 and showed a normal LVEF of 65% and normal LV size and wall thickness. His RV size was mildly enlarged and has mildly elevated right atrial pressure. There was no significant valvular disease. Cardiac MRI was done prior to discharge and he will follow up with cardiology for the final results. He was having some intermittent chest pain and SOB and was recommended to use OTC ibuprofen 600 mg BID per cardiology. Reports that his chest pain and shortness of breath is slowly resolving. His symptoms are mild and infrequent.
Fever 101.5, aches, chills, soreness, fatigue, diarrhea, cough, runny nose
arm was red & had 3 whelps pt was taken to MD 1PM & @ 1030PM taken to ER for fever 103;
High fever unable to go down with tylenol fever of over 103 had to rush to hospital.
5/3/16 fever 103 - seen 5/4/16 with fever 103 rectally. Fevers started yesterday, 101.2, 102 today, received vaccines 2 days ago, PROQUAD and Hep A.
First, severe body aches, even skin and gums. Then, body aches every other day, feeling of moisture in lungs, asthma, and then diagnosis of lung infection with negative COVID test.
shingles; shingles neuralgia; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 66 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or around 05-FEB-2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions.   On an unspecified date, the patient experienced shingles and shingles neuralgia. On an unspecified date, the patient was treated by a physician for shingles and shingles neuralgia. The outcome of the events shingles and shingles neuralgia was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
metabolic encephalopathy, COVID, renaltransplant reciepient AKI
Pt called said was running fever and redness was spreading told pt to get to dr tonight. Diagnosed with cellulitis infection. Dr put on KEFLEX and BACTRIM for infection.
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated IM into the upper arm with an entire dose of Gardasil.  After vaccination, the patient experienced syncope.  Unspecified medical attention was sought.  On an unknown date, the patient recovered.  No product quality complaint was involved.  This is one of two reports from the same source.  Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history was not reported. On 28-MAY-2014 the patient was vaccinated with ZOSTAVAX (second dose, dose, units, route of administration, anatomical location, lot number was not reported). Concomitant medications were not reported. The reporter stated that the patient was inadvertently administered a second dose of ZOSTAVAX, on 28-MAY-2104 (reported as yesterday), in May 2012, about 2 years after administration of the first dose ZOSTAVAX (dose, units, route of administration, anatomical location, lot number was not reported). No adverse effect reported. Additional information has been requested.